It is not only the busy business and entertainment capital of India but also the heartbeat of the pharmaceutical industry of India, the city of Mumbai. With time progressing towards 2025, the image of the city as an international pharmaceutical and biotechnology hub keeps getting stronger. Mumbai plays host to the headquarters of many of the country giants and Indian subsidiaries of the multinationals and is a leader in the field of healthcare innovation, manufacturing, and supply chains around the globe. This ecosystem, a combination of advanced research, a huge pool of talent, and a strong infrastructure, makes the city an essential contributor to the fulfillment of domestic and global healthcare needs.
The Indian pharmaceutical industry is undergoing an exponential rise and the home market is expected to reach a staggering US$ 65 billion by 2024 and US$ 130 billion by 2030. One of the major drivers of this expansion is the impressive export market of the country that exceeded US$ 25 billion in the 2023-24 fiscal year. The key to this success is Maharashtra, the state which has the most number of pharmaceutical firms in India with more than 3,000 registered units. This turns its capital, Mumbai, into the unquestionable hub of India’s pharmaceutical environment.
In fact, some of the leading pharma companies in India are headquartered in Mumbai, making it a strategic hub for innovation, production, and exports. This article will study the top 10 pharma companies in Mumbai that are leading the pace in 2025, their legacy, their strong points, their contribution to the world and the innovative products that are transforming lives all over the world.
Overview of Mumbai as a Pharmaceutical and Biotech Hub
The rise of pharma companies in Mumbai as one of the leading pharmaceutical and biotechnology centers is not by chance. It is a product of a combination of strategic strengths that have been developed over decades.
- Corporate Headquarters: The city has corporate headquarters of most of the major pharmaceutical firms in India, which allows strategic decision-making and global management.
- Pharmaceutical Production: Mumbai and its environs such as Thane, Navi Mumbai and the broader state of Maharashtra constitute a huge pharmaceutical manufacturing zone, which produces a wide variety of formulations, active pharmaceutical ingredients (APIs) and biologics.
- Research and Development orientation: The city has many state of art R&D facilities where scientists are working at drug discovery, process development and clinical studies and innovation in this sector is happening.
- Vibrant Biotech Hub: Mumbai is an emerging hub in the biotechnology industry, and the number of startups and well-established companies working on new biologics, biosimilars, and diagnostics is on the rise.
- Logistical Advantage: The city of Mumbai has one of the busiest ports as well as an international airport, which provides an unparalleled connectivity to the import of raw materials and export of complete pharmaceutical products to more than 200 countries.
Why Mumbai is a Key Pharmaceutical Hub of India
The eminence of Mumbai as a pharmaceutical center is due to a number of reasons:
- Historical Legacy: The city enjoys a long history in the pharmaceutical industry and some of the companies were founded many decades ago, creating an extensive base of experience and infrastructure.
- Talent Pool: Mumbai has a large pool of talent with scientists, researchers, pharmacists and business development people due to the many institutions of higher learning and research centers in the city.
- Infrastructure and Connectivity: It has a well-developed infrastructure, a major port and good air connectivity, which helps in import of raw materials and export of finished products, thus making it a perfect place to have a global presence of pharmaceutical industries.
- Financial Capital: Mumbai being the financial center of India offers ready access to capital, investment and banking facilities, which are essential in the capital intensive pharmaceutical sector.
- Regulatory environment: Regulatory authorities and well-established legal framework of pharma products also enhance the reputation of Mumbai as a trusted and compliant location of pharma companies.
- Research and Development (R&D): A large number of firms in Mumbai invest a lot in R&D, which helps in the creation of new drugs, therapies and enhanced manufacturing processes. There is heightened use of technologies such as Generative AI in drug discovery and clinical trials in the city.
- Market Access: Mumbai has the best access to the Indian domestic market which is the largest market in the world, and a strategic location to access the international markets especially the US, Africa and Europe.
Comparison Table: Top 10 Pharma Companies in Mumbai (Leading in 2025)
| Company Name | Founded In | Type | Key Products (Examples) | Certifications (Common) | Best For |
| 1. Sun Pharmaceutical Industries Ltd. | 1983 | Generics, Specialty, APIs | Psychiatry, Cardiology, Dermatology, Oncology, OTC products | USFDA, EMA, WHO-GMP, TGA | Largest Indian pharma, global generics leader |
| 2. Cipla Ltd. | 1935 | Generics, APIs, Specialty | Respiratory (Foracort), Anti-infectives, HIV/AIDS drugs, Nicotex, Cofsils | USFDA, EMA, WHO-GMP | Respiratory & affordable healthcare, global reach |
| 3. Lupin Ltd. | 1968 | Generics, Branded, Biosimilars, APIs | Cardiovascular, Respiratory, Diabetology, Anti-infectives, CNS | USFDA, EMA, WHO-GMP | Strong R&D, diverse portfolio, global presence |
| 4. Glenmark Pharmaceuticals Ltd. | 1977 | Branded, Generics, OTC | Dermatology, Respiratory (Ryaltris), Oncology, COVID-19 treatments (FabiFlu) | USFDA, EMA, WHO-GMP | Dermatology & respiratory segment innovation |
| 5. Abbott India Ltd. | 1944 | Branded Generics, Nutritionals | Wide range across therapeutic areas, infant nutrition, diagnostics | USFDA, ISO, GMP | Established market presence, diverse healthcare |
| 6. Ajanta Pharma Ltd. | 1973 | Branded Generics | Ophthalmology, Dermatology, Cardiology, Pain Management | USFDA, WHO-GMP | Specialty focus, particularly ophthalmology |
| 7. Alkem Laboratories Ltd. | 1973 | Generics, Formulations, Nutraceuticals | Anti-infectives (Clavam, Taxim-O), Gastrointestinal, Pain relief | USFDA, WHO-GMP | Leading in anti-infectives and domestic market |
| 8. Pfizer Ltd. | 1950s | Innovator, Specialty | Vaccines, Oncology, Rare diseases, Anti-infectives (local portfolio based on global) | USFDA, EMA, ISO, GMP | Global innovator with strong local presence |
| 9. Macleods Pharmaceuticals Ltd. | 1986 | Generics, Formulations | Anti-infectives, Cardiovascular, Diabetes, HIV/AIDS, Malaria | WHO-GMP, various international | Affordable medicines, strong presence in therapies |
| 10. Piramal Pharma Ltd. | 1988 | CDMO, Generics, OTC | Inhalation Anesthetics, Pain Management, Injectable Anti-infectives | USFDA, EMA, WHO-GMP | Contract Development & Manufacturing (CDMO) services |
Top 10 Pharma Companies in Mumbai in 2025
1. Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical industries Ltd. has written one of the most phenomenal growth histories of Indian pharmaceutical industry. Started with a mere five products to cure psychiatric disorders in 1983, it has grown to be the biggest pharmaceutical firm in India and the fourth-biggest specialty generic drug company in the world. Its history has been characterized by a number of strategic acquisitions, including the acquisition of Ranbaxy Laboratories in 2014, which greatly increased its global presence as well as its product range. It is one of the best pharma companies in Mumbai.
The incessant emphasis on research and development and the quality of the manufacturing capabilities have helped the company to provide a broad range of quality and affordable medicines to patients across more than 100 countries. The innovative approach of Sun Pharma manifests itself through its increased pipeline of specialty products, especially in the therapeutic lines of dermatology, ophthalmology, and oncology, which are likely to become major growth drivers in the future.
Global Presence / Operations:
- Production plants located in six continents.
- Good market in the United States, India and other emerging markets.
- Direct representation in more than 100 countries.
- More than 38,000 employees of multicultural workforce.
Key Products:
- Specialty Brands: Ilumya (psoriasis), Cequa (dry eye disease) and Odomzo (basal cell carcinoma).
- Generics: A large range of generics in different therapeutic areas.
- APIs: A major producer of active pharmaceutical ingredients.
- The over-the-counter (OTC): A variety of products used in consumer healthcare.
Company Details:
- Founded In: 1983
- Founder: Dilip Shanghvi
- Website: https://sunpharma.com/
- Address: SUN HOUSE, CTS No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400 063, Maharashtra, India.
2. Cipla Ltd.

Cipla is more than eight decades old and the mission of the company has always been of caring about life. The company was established in 1935 with a vision of making India self-sufficient in healthcare and since then it has been in the forefront in providing affordable and accessible medicines. The history of Cipla is pegged on its pioneering work in ensuring that life-saving drugs reach the people who need it the most, most notably its contribution to the availability of affordable anti-retroviral (ARV) drugs to HIV/AIDS patients in Africa, which changed the war against the pandemic globally.
The company has good leadership in respiratory therapy in India and other major emerging markets. It is one of the best pharma companies in Mumbai. Cipla has a huge product base with more than 1500 products in different therapeutic sectors. In its march towards the future, Cipla has remained committed to its core business, to investment in innovation and to building a global presence in its major markets, all in keeping with its original philosophy of compassion and affordability.
Global Presence / Operations:
- Operation in more than 80 states.
- Production plants in India, South Africa, the USA and other places.
- Good market share in India, South Africa and America.
- Global pharmaceutical players strategic alliances.
Key Products:
- Respiratory: An entire portfolio of inhalers and other asthma and COPD products.
- Anti-retrovirals: One of the major providers of ARVs against HIV.
- Urology and Cardiology: An expanding list of medicines in these therapeutic fields.
- Consumer Healthcare: A portfolio of wellness products that are available over the counter.
Company Details:
- Founded In: 1935
- Founder: Dr. Khwaja Abdul Hamied
- Website: https://www.cipla.com/
- Address: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai 400 013, Maharashtra, India.
3. Lupin Ltd.

Lupin Ltd. has gone through a transformation since its inception as a domestic Indian pharmaceutical company to an international player that has a strong hold in the developed and the emerging markets. The company was started in 1968 and it specialised in the production of vitamins. It subsequently made a name by being among the largest producers of anti-tubercular drugs in the world. In the present scenario, Lupin possesses a rich and wide product portfolio with a multifaceted range of therapeutic areas.
Recognized as one of the top pharma companies in Mumbai, the company enjoys heavy emphasis on research and development with a pipeline of generic and specialty products. The strong organic growth in major markets and acquisitions which have boosted its presence across the globe and its therapeutic strengths have driven the growth of Lupin. The company is focused on quality, compliance and affordability of healthcare solutions to patients across the globe.
Global Presence / Operations:
- Operation in more than 100 countries.
- The United States, India, Japan and Europe are the major markets.
- Factories in India, Japan, the USA, Mexico and Brazil.
- An international workforce of more than 20,000 employees.
Key Products:
- Cardiovascular: A market leader in the cardiovascular market in India.
- Anti-infectives and Diabetology: Well established portfolios in these therapeutic areas.
- Pediatrics and CNS: Increasing presence in pediatrics and CNS.
- APIs: It is a major producer of active pharmaceutical ingredients.
Company Details:
- Founded In: 1968
- Founder: Dr. Desh Bandhu Gupta
- Website: https://www.lupin.com/
- Address: 3rd Floor, Kalpataru Inspire, Off Western Express Highway, Santacruz (East), Mumbai 400 055, Maharashtra, India.
4. Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. is a global pharmaceutical company that has created a niche by focusing on discovery of novel molecules and development of high quality generic products. Since its foundation in 1977, Glenmark has evolved as a generic drug company to a company with a strong pipeline of new chemical entities (NCEs) and new biological entities (NBEs). It is one of the best pharma companies in Mumbai. The company is very strong in the dermatology, respiratory and oncology segment.
The innovation is one of the key elements of Glenmark as it is witnessed through its advanced R&D centers and partnership with the world-leading pharmaceutical companies. It is in the process of fortifying its generics business but its long-term goals are to be a major innovation-driven pharmaceutical company.
Global Presence / Operations:
- Business in more than 80 countries.
- High concentration in the United States, India, Europe and Latin America.
- Plants in India, the USA, Argentina, and the Czech Republic.
- More than 14,000 employees of a diverse team.
Key Products:
- Dermatology: One of the most developed players in the dermatology segment and a broad line of products.
- Respiratory: Novel products in treatment of respiratory disorders.
- Oncology: An expanding cancer drug portfolio.
- Generics: Good generic product pipeline to different markets.
Company Details:
- Founded In: 1977
- Founder: Gracias Saldanha
- Website: https://www.glenmarkpharma.com/
- Address: Glenmark House, B. D. Sawant Marg, Chakala, Andheri (East), Mumbai 400 099, Maharashtra, India.
5. Alkem Laboratories Ltd.

Alkem Laboratories Ltd. has established itself as one of the foremost companies operating within the space of branded generics in the Indian pharmaceutical space. Since its founding in 1973, Alkem has consistently been found in the highest rankings for pharmaceutical companies in Mumbai based on domestic sales. Alkem has a very strong position within its anti-infective segment and has some brands that are largely known by most households in India. The driving factor behind Alkem’s success is due the company’s extremely strong marketing and distribution network that allow it reach most of India by all means of transportation.
While Alkem has dominated the marketplace and retained market leadership domestically, it has been stitching together an international business as well; in particular, a US business that is also experiencing steady growth over time. Alkem is generally known for its high quality of manufacturing and breadth of product range.
Global Presence / Operations:
- Operations in 40+ countries.
- Stronghold in the Indian market.
- Strong presence in US, Europe, Australia and more.
- Multiple manufacturing facilities in India and the US.
Key Products:
- Anti-infective: A market leader in anti-infectives in India.
- Gastro-intestinal, Pain management and Vitamins: Strong portfolio in these therapeutic areas.
- Branded Generics: Large range of branded generics portfolio.
- APIs: excitation of active pharmaceutical ingredients.
Company Details:
- Founded In: 1973
- Founder: Samprada Singh
- Website: https://www.alkemlabs.com/
- Address: Alkem House, Senapati Bapat Marg, Lower Parel, Mumbai 400 013, Maharashtra, India.
6. Abbott India Ltd.

Abbott India Ltd., the Indian subsidiary of multinational healthcare company Abbott, has a rich history in the country, dating back to 1910. As one of the most successful multinational pharmaceutical companies in India, Abbott India has a strong portfolio of branded generics that are trusted and consumable across different therapeutic areas. It is one of the best pharma companies in Mumbai. The brand has a strong presence in areas such as women’s health, gastroenterology metabolic disorders and the central nervous system.
Abbott’s commitment to scientific evidence-based excellence, and its strong understanding of the Indian healthcare system allows it to develop strong engagement with healthcare professionals and patients. Beyond its pharmaceutical business, Abbott has also a strong presence in the diagnostics and nutritional markets in India.
Global Presence / Operations:
- One of the global Abbott family members operating in over 160 countries.
- A strong pan-India presence with a diverse distribution network.
- Our manufacturing facilities in India all adhered to global quality standards.
Key Products:
- Branded Generics: Our portfolio consists of over 100 branded products that you know and trust. Brands like Thyronorm, Duphaston, and Udiliv.
- Nutritional Products: We offer science-based nutritional products for all stages of life.
- Diagnostics: We are a market leader in diagnostic instruments and tests.
- Medical Devices: We have a portfolio of medical devices that impact lives.
Company Details:
- Founded In: 1944 (in India)
- Founder: (Indian subsidiary of Abbott, founded by Dr. Wallace C. Abbott)
- Website: https://www.abbott.co.in/
- Address: 16th Floor, Godrej BKC, Plot – C, “G” Block, Bandra-Kurla Complex, Bandra (East), Mumbai 400 051, Maharashtra, India.
7. Pfizer Ltd.

Pfizer is a leading biopharmaceutical company in the world with a large presence in India in the form of its subsidiary, Pfizer Ltd. Recognized among the multinational pharma companies in Mumbai, the company has dedicated more than 70 years to delivering scientific innovations and world-class medicines to the patients in India. Pfizer has a combination of innovative products, old brands and vaccines in India. Its vaccines and other vital medicines have been very instrumental in the health of the Indian population.
Pfizer pays much attention to research and development to help solve some of the hardest diseases of nowadays. The quality, safety and compliance of the company is very strong and the company remains a trusted partner of healthcare professionals and patients throughout the country.
Global Presence / Operations:
- An international bio-pharmaceutical corporation that has operations across the globe.
- Good portfolio of major therapeutic areas in India.
- Goa based manufacturing plant that sells products to more than 100 countries.
Key Products:
- Vaccines: One of the greatest suppliers of vaccines including the pneumococcus conjugate vaccine.
- Innovative Medicines: A collection of oncology, inflammation and immunology and rare disease medicines.
- Established Brands: Various brands that are well known and trusted.
- Consumer Healthcare: More than 200 over-the-counter products.
Company Details:
- Founded In: 1950 (in India)
- Founder: (Indian subsidiary of Pfizer Inc., founded by Charles Pfizer and Charles F. Erhart)
- Website: https://www.pfizer.co.in/
- Address: The Capital, 1802, 18th Floor, Plot No. C-70, ‘G’ Block, Bandra-Kurla Complex, Bandra (East), Mumbai 400 051, Maharashtra, India.
8. Sanofi India Ltd.

Sanofi India Ltd., a subsidiary of Sanofi, a global healthcare major, has been meeting the healthcare requirements of the country for more than 60 years. The company has a wide range of products, which are pharmaceuticals, consumer healthcare products and vaccines. Sanofi has a good market in diabetes management where its insulin products are common in the country. The company also plays an important role in the area of vaccines and is a part of the Indian national public health programs.
Sanofi has been an innovative company as seen in its quest to provide new and better disease treatments to patients in India. The manufacturing plants of the company in India are of the top international quality.
Global Presence / Operations:
- A subsidiary of an international healthcare organization that operates in more than 100 countries.
- A good base in the Indian market and extensive distribution network.
- Manufacturing facilities in India that supply both the local and the global markets.
Key Products:
- Diabetes Care: One of the most popular suppliers of insulin and other diabetes control products such as Lantus and Toujeo.
- Essential Medicines: a wide range of medicines that cover many therapeutic areas.
- Vaccines: One of the main suppliers of vaccines against different diseases.
- Consumer Healthcare: A wellness product line of over-the-counter products.
Company Details:
- Founded In: 1956 (in India)
- Founder: (Indian subsidiary of Sanofi S.A.)
- Website: https://www.sanofi.in/
- Address: Sanofi House, CTS No. 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400 072, Maharashtra, India.
9. Merck India

Merck is one of the largest science and technology organizations in the world with its healthcare operation in India known as MSD Pharmaceuticals Pvt. Ltd. It is research-intensive and focuses much on the company and is determined to introduce new medicines and vaccines in India. In India, the portfolio of Merck consists of a variety of products in the fields of oncology, vaccines, and other specialty care products. It is one of the best pharma companies in Mumbai.
The company has also been quite active in the field of oncology and its immuno-oncology therapy is one of the major developments in cancer treatment. Merck is also a key market player in the vaccines market, which helps in prevention of infectious diseases. The operations of the company in India are based on its dedication to scientific discovery and patient-centric nature.
Global Presence / Operations:
- Belonging to an international science and technology conglomerate operating in 66 countries.
- Specialty care and oncology in India.
- India is highly committed to clinical research.
Key Products:
- Oncology: New-fangled treatments to treat different cancers, such as Keytruda.
- Vaccines: A line of vaccines to prevent infectious diseases such as HPV.
- Specialty Care: Diabetes and other chronic illnesses medicines.
- Animal Health: Various types of veterinary medicines and vaccines.
Company Details:
- Founded In: 1967 (in India)
- Founder: (Indian subsidiary of Merck & Co., Inc.)
- Website: https://www.msd-india.com/
- Address: 10th & 11th Floor, Platina, Plot No. C-59, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400051, Maharashtra, India.
10. Dr. Reddy’s Laboratories

Based in Hyderabad, Dr. Reddy Laboratories has large and strategic presence in Mumbai which is a pivotal point in its commercial activities, business advancement and international cooperation. Dr. Reddy was established in 1984 with the aim of offering affordable and innovative medicines and today it has emerged to be a global pharmaceutical company.
The company began as an active pharmaceutical ingredients (APIs) supplier and it has now developed into a vertically integrated organization with a robust portfolio of generic as well as proprietary products. Dr. Reddy has an emphasis on research and development and has a product pipeline that focuses on different therapeutic areas. Its quality and patient-centric approach have made the company a reputable healthcare provider across the world.
Global Presence / Operations:
- Availability of more than 66 countries.
- The USA, India, Russia and Europe are major markets.
- India, the UK, the USA, and China manufacturing units.
- More than 24,000 employees are located across the world.
Key Products:
- APIs: One of the major suppliers of active pharmaceutical ingredients in the world.
- Generics: Expansive generic medicine portfolio of expansive therapy.
- Proprietary Products: An increasing range of new products.
- Biosimilars: An emphasis on the creation and sale of inexpensive biosimilars.
Company Details:
- Founded In: 1984
- Founder: Dr. Kallam Anji Reddy
- Website: https://www.drreddys.com/
- Address: (Mumbai Office) HDIL Towers, 6th Floor, Anant Kanekar Marg, Bandra (East), Mumbai 400051, Maharashtra, India.
How to Choose the Right Company
To different stakeholders, the right pharma companies in Mumbai will depend on what they want and what they need:
- As a Job Seeker: Look at the best pharma companies. companies that have a solid R&D, positive employee ratings and that focus on therapeutic areas where you have expertise. Seek out the companies that invest in the latest technologies such as AI.
- Investors: Evaluate financial results, market share, product pipeline, and geographic coverage and future expansion plans (e.g., entering biosimilars or specialty drugs).
- Business Partnerships (e.g. CDMO): Seek companies with a strong manufacturing infrastructure, respective certifications, good regulatory adherence, and experience of successful partnerships.
- Healthcare Providers/Patients: Give preference to those companies with reputations of quality, efficacy, affordable pricing and diversity of products that meet severe health requirements. Do regulatory approvals and availability of the products.
- To Suppliers: Find pharma companies in Mumbai with a consistent business operation, equitable procurement process, and quality and ethical practices.
Challenges and Opportunities
The pharmaceutical environment in Mumbai, and India in general, is quite dynamic, which implies both opportunities and challenges.
Challenges:
- Growing Competition: The Indian pharma companies in Mumbai is very competitive particularly in the generics market that is subjected to price competition.
- Regulatory Scrutiny: Greater regulatory oversight (by international regulatory agencies, such as USFDA, EMA, etc.) requires constant compliance with high-quality and manufacturing standards.
- Intellectual Property Rights: The issue of striking a balance between innovation and affordable access to medicines particularly in regard to patent expiries and the introduction of generics is a complicated matter.
- Talent Retention: This is because retaining and attracting the best talent in a competitive market is not easy.
Opportunities:
- Expanding Home Market: India has a large and expanding population, and with the rising awareness and access to healthcare, there is a high demand in the home market of pharmaceuticals.
- Worldwide Generic Leadership: India remains a global leader in generic drug production with a high potential of exportation to the regulated markets.
- Biosimilars and Specialty Drugs: The emphasis on creating and producing biosimilars and high-value specialty drugs would provide more revenue opportunities and place companies further along the value chain.
- Contract Development and Manufacturing Organization (CDMO): Indian firms are gaining popularity as partners of international pharma majors in the CDMO services owing to cost benefits and technical proficiency.
- Digital Transformation and AI: The use of AI, machine learning and digital technologies in research and development, production, and supply chain operations can increase efficiency and make drug development much faster.
Conclusion
In 2025, the pharma companies in Mumbai are a thriving and dynamic environment, and this is a testimony of the Mumbai spirit of innovation and enterprise. The companies discussed in the top 10 of this article are the best performing in this industry and each of them has its own strength and contribution to global healthcare. These firms are not only dominating the Indian pharmaceutical market, but are also leaving a big mark in the global market, having pioneered affordable medicines and being leaders in innovative research. Although the challenges exist, opportunities to grow and innovate are enormous. With Mumbai keeping its pharmaceutical powerhouse nurtured, it will even more significantly contribute to the future of medicine and the health and well-being of the people of the world.
FAQs
1. Why is Mumbai a pharmaceutical center?
The strategic position of Mumbai with a significant port and airport, a huge talent base of skilled professionals, strong infrastructure.
2. Does Mumbai pharma industry have any startup prospects?
Yes, Mumbai is emerging as a startup hub in the pharmaceutical and biotechnology sector and of interest in the pharmaceutical and biotechnology sector is in areas such as digital health, diagnosis, and novel drug discovery.
3. Which are the major growth drivers of the pharmaceutical industry in Mumbai?
The major growth opportunities are the increased domestic demand of healthcare, the expanding export market, the augmented attention to research and innovation, and the augmented opportunities in contract manufacturing and biosimilars.
4. What are the government policies that are helping the pharma industry in Mumbai?
The government is supportive in the form of creating Special Economic Zones (SEZs), research and development investment, and policies, which encourage local production and export.